Current evidence suggests that insulin can be safely administered to patients with heart failure, and the use of insulin does not lead to an increased risk of heart failure hospitalization, as shown in the ORIGIN and the DEVOTE study [58, 59]. This evidence concerns the gene INS and heart failure.